These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 12023766

  • 21. [Expression of secretory leukocyte proteinase inhibitor in human bronchial epithelial cell is downregulated by transforming growth factor-beta1/Smads pathway].
    Niu RC, Luo BL, Hu CP, Feng JT.
    Zhonghua Yi Xue Za Zhi; 2008 Aug 05; 88(30):2117-21. PubMed ID: 19080472
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Downregulation of secretory leukocyte proteinase inhibitor in chronic obstructive lung disease: the role of TGF-beta/Smads signaling pathways.
    Luo BL, Niu RC, Feng JT, Hu CP, Xie XY, Ma LJ.
    Arch Med Res; 2008 May 05; 39(4):388-96. PubMed ID: 18375249
    [Abstract] [Full Text] [Related]

  • 25. Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing.
    Ashcroft GS, Lei K, Jin W, Longenecker G, Kulkarni AB, Greenwell-Wild T, Hale-Donze H, McGrady G, Song XY, Wahl SM.
    Nat Med; 2000 Oct 05; 6(10):1147-53. PubMed ID: 11017147
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The secretory leukocyte protease inhibitor is a type 1 insulin-like growth factor receptor-regulated protein that protects against liver metastasis by attenuating the host proinflammatory response.
    Wang N, Thuraisingam T, Fallavollita L, Ding A, Radzioch D, Brodt P.
    Cancer Res; 2006 Mar 15; 66(6):3062-70. PubMed ID: 16540655
    [Abstract] [Full Text] [Related]

  • 29. Secretory leukocyte protease inhibitor and its potential interactions with elastase and cathepsin B in gingival crevicular fluid and saliva from patients with chronic periodontitis.
    Cox SW, Rodriguez-Gonzalez EM, Booth V, Eley BM.
    J Periodontal Res; 2006 Oct 15; 41(5):477-85. PubMed ID: 16953825
    [Abstract] [Full Text] [Related]

  • 30. Putative stem cell activity of human endometrial epithelial and stromal cells during the menstrual cycle.
    Schwab KE, Chan RW, Gargett CE.
    Fertil Steril; 2005 Oct 15; 84 Suppl 2():1124-30. PubMed ID: 16210003
    [Abstract] [Full Text] [Related]

  • 31. Up-regulation of secretory leukocyte protease inhibitor (SLPI) in the brain after ischemic stroke: adenoviral expression of SLPI protects brain from ischemic injury.
    Wang X, Li X, Xu L, Zhan Y, Yaish-Ohad S, Erhardt JA, Barone FC, Feuerstein GZ.
    Mol Pharmacol; 2003 Oct 15; 64(4):833-40. PubMed ID: 14500739
    [Abstract] [Full Text] [Related]

  • 32. Constitutive and regulated secretion of secretory leukocyte proteinase inhibitor by human intestinal epithelial cells.
    Si-Tahar M, Merlin D, Sitaraman S, Madara JL.
    Gastroenterology; 2000 Jun 15; 118(6):1061-71. PubMed ID: 10833481
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Attenuated induction of epithelial and leukocyte serine antiproteases elafin and secretory leukocyte protease inhibitor in Crohn's disease.
    Schmid M, Fellermann K, Fritz P, Wiedow O, Stange EF, Wehkamp J.
    J Leukoc Biol; 2007 Apr 15; 81(4):907-15. PubMed ID: 17200145
    [Abstract] [Full Text] [Related]

  • 35. Human immunodeficiency virus type-1 (HIV-1) replication is unaffected by human secretory leukocyte protease inhibitor.
    Turpin JA, Schaeffer CA, Bu M, Graham L, Buckheit RW, Clanton D, Rice WG.
    Antiviral Res; 1996 Mar 15; 29(2-3):269-77. PubMed ID: 8739605
    [Abstract] [Full Text] [Related]

  • 36. Helicobacter pylori infection, but not low-dose aspirin, results in a local reduction of the secretory leukocyte protease inhibitor in gastroduodenal mucosa.
    Wex T, Ye S, Treiber G, Vieth M, Roessner A, Malfertheiner P.
    Helicobacter; 2006 Feb 15; 11(1):31-8. PubMed ID: 16423087
    [Abstract] [Full Text] [Related]

  • 37. The secretory leukocyte protease inhibitor gene is a target of epidermal growth factor receptor action in endometrial epithelial cells.
    Velarde MC, Parisek SI, Eason RR, Simmen FA, Simmen RC.
    J Endocrinol; 2005 Jan 15; 184(1):141-51. PubMed ID: 15642791
    [Abstract] [Full Text] [Related]

  • 38. Secretory leucoprotease inhibitor binds to NF-kappaB binding sites in monocytes and inhibits p65 binding.
    Taggart CC, Cryan SA, Weldon S, Gibbons A, Greene CM, Kelly E, Low TB, O'neill SJ, McElvaney NG.
    J Exp Med; 2005 Dec 19; 202(12):1659-68. PubMed ID: 16352738
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.